RLAY · Insider trading · 13F holders · Congress trades
Relay Therapeutics, Inc. (RLAY)
Who is buying and selling RLAY: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 29
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $120.4M
- Congress trades, 12 months
- 1
RLAY at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 5 RLAY insiders filed 9 sales worth $120.4M on SEC Form 4, and no open-market purchases; 8 of the sales were pre-planned under Rule 10b5-1.
- 29 13F filers hold RLAY among their 50 largest positions, worth $2.1B combined, including Joseph Edelman, Oleg Nodelman and Julian and Felix Baker. The biggest bets by portfolio weight are Casdin Capital, LLC (15.0%), Commodore Capital LP (13.4%) and Spruce Street Capital LP (11.0%). In their latest 13Fs, 1 manager opened a new position and 9 added to one.
- Members of Congress have disclosed 1 RLAY trade since 2023, 0 purchases and 1 sale in the past year; the latest was Daniel S. Goldman (D-NY), selling $1K–15K on Jul 12, 2023.
- RLAY last closed at $19.47 on Oct 29, 2026.
RLAY insider trading
Between Aug 1, 2026 and Oct 29, 2026, 5 RLAY insiders filed 9 sales worth $120.4M on SEC Form 4, and no open-market purchases; 8 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Patel Sanjiv | President and CEO, Director | Sale10b5-1 | 48,199 | $18.10 | $872K | SEC |
| Oct 8, 2026 | Catinazzo Thomas | Chief Financial Officer | Sale10b5-1 | 17,717 | $18.59 | $329K | SEC |
| Sep 9, 2026 | Patel Sanjiv | President and CEO, Director | Sale10b5-1 | 48,199 | $18.94 | $913K | SEC |
| Sep 9, 2026 | Catinazzo Thomas | Chief Financial Officer | Sale10b5-1 | 17,717 | $18.94 | $336K | SEC |
| Sep 9, 2026 | Bergstrom Donald A | President, R&D | Sale10b5-1 | 8,530 | $18.97 | $162K | SEC |
| Aug 28, 2026 | SVF Pauling (Cayman) Ltd | 10% Owner | Sale | 6,000,000 | $19.40 | $116.4M | SEC |
| Aug 28, 2026 | Rahmer Peter | See remarks | Sale10b5-1 | 4,508 | $20.03 | $90K | SEC |
| Aug 18, 2026 | Patel Sanjiv | President and CEO, Director | Sale10b5-1 | 48,199 | $20.33 | $980K | SEC |
| Aug 18, 2026 | Catinazzo Thomas | Chief Financial Officer | Sale10b5-1 | 17,717 | $19.74 | $350K | SEC |
Who owns RLAY? Hedge funds and superinvestors
29 13F filers hold RLAY among their 50 largest positions, worth $2.1B combined, including Joseph Edelman, Oleg Nodelman and Julian and Felix Baker. The biggest bets by portfolio weight are Casdin Capital, LLC (15.0%), Commodore Capital LP (13.4%) and Spruce Street Capital LP (11.0%). In their latest 13Fs, 1 manager opened a new position and 9 added to one.
Superinvestors holding RLAY: Joseph Edelman 4.1% · Oleg Nodelman 0.6% · Julian and Felix Baker 0.3%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Sb Investment Advisers (UK) LtdWealth manager | 6.8% | $522.1M | 27,904,963 | +0.0% shares | Q2 2026 |
| Casdin Capital, LLCHedge fund | 15.0% | $300.0M | 16,035,240 | +11.2% shares | Q2 2026 |
| Joseph EdelmanHedge fund | 4.1% | $263.9M | 14,106,187 | +44.7% shares | Q2 2026 |
| Commodore Capital LPHedge fund | 13.4% | $224.5M | 12,000,000 | -29.4% shares | Q2 2026 |
| Nextech Invest Ltd.Hedge fund | 6.0% | $126.8M | 6,776,506 | +22.6% shares | Q2 2026 |
| Bellevue Group AGInvestment manager | 2.4% | $115.7M | 6,185,970 | -20.6% shares | Q2 2026 |
| TCG Crossover Management, LLCHedge fund | 1.9% | $80.0M | 4,273,356 | +0.0% shares | Q2 2026 |
| Siren, L.L.C.Investment manager | 1.4% | $68.3M | 3,650,000 | — | Q2 2026 |
| Kynam Capital Management, LPHedge fund | 3.4% | $61.7M | 3,300,000 | +131.7% shares | Q2 2026 |
| Spruce Street Capital LPHedge fund | 11.0% | $55.8M | 2,984,125 | +0.0% shares | Q2 2026 |
| Julian and Felix BakerHedge fund | 0.3% | $52.9M | 2,826,783 | — | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 2.8% | $45.2M | 2,415,672 | +2.4% shares | Q2 2026 |
| Elmind Capital, LPHedge fund | 6.9% | $27.4M | 1,465,279 | +172.9% shares | Q2 2026 |
| Alphabet Inc.Corporation | 0.0% | $26.4M | 1,410,029 | -9.9% shares | Q2 2026 |
| Foresite Capital Management IV, LLCHedge fund | 8.1% | $23.4M | 1,250,000 | +25.0% shares | Q2 2026 |
| Affinity Asset Advisors, LLCHedge fund | 1.0% | $19.6M | 1,050,000 | — | Q2 2026 |
| Frazier Life Sciences Management, L.P.Hedge fund | 0.4% | $19.0M | 1,015,693 | New | Q2 2026 |
| Squadron Capital Management LLCHedge fund | 6.2% | $18.1M | 970,000 | +44.2% shares | Q2 2026 |
| Timothy G. Youngquist 2020 Irrevocable TrustInvestment manager | 2.9% | $14.5M | 801,464 | +0.0% shares | Q3 2026 |
| Oleg NodelmanHedge fund | 0.6% | $13.1M | 697,948 | -63.4% shares | Q2 2026 |
| Tetragon Partners GP LtdHedge fund | 1.7% | $10.7M | 570,311 | +214.1% shares | Q2 2026 |
| Rhenman & Partners Asset Management ABHedge fund | 1.0% | $10.6M | 566,000 | — | Q2 2026 |
| HighVista Strategies LLCHedge fund | 2.2% | $9.5M | 506,235 | +20.0% shares | Q2 2026 |
| Boxer Capital Management, LLCHedge fund | 0.6% | $8.4M | 450,000 | — | Q2 2026 |
| Diadema Partners LPHedge fund | 1.6% | $4.3M | 230,677 | — | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 0.6% | $3.3M | 178,222 | -30.9% shares | Q2 2026 |
| ICONIQ Capital, LLCHedge fund | 0.1% | $1.8M | 94,697 | — | Q2 2026 |
| Exome Asset Management LLCHedge fund | 0.5% | $889K | 47,531 | -82.9% shares | Q2 2026 |
| Brandywine Managers, LLCHedge fund | 0.4% | $719K | 38,429 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 28). Screen RLAY in the grand portfolio →
RLAY stock trades by members of Congress
Members of Congress have disclosed 1 RLAY trade since 2023, 0 purchases and 1 sale in the past year; the latest was Daniel S. Goldman (D-NY), selling $1K–15K on Jul 12, 2023.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Aug 13, 2023 | Daniel S. GoldmanD-NY · House | Sale | $1K–15K | Jul 12, 2023 | +45.3% |
RLAY questions and answers
Are insiders buying RLAY stock?
Between Aug 1, 2026 and Oct 29, 2026, 5 RLAY insiders filed 9 sales worth $120.4M on SEC Form 4, and no open-market purchases; 8 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own RLAY?
29 13F filers hold RLAY among their 50 largest positions, worth $2.1B combined, including Joseph Edelman, Oleg Nodelman and Julian and Felix Baker. The biggest bets by portfolio weight are Casdin Capital, LLC (15.0%), Commodore Capital LP (13.4%) and Spruce Street Capital LP (11.0%). In their latest 13Fs, 1 manager opened a new position and 9 added to one.
Has Congress traded RLAY?
Members of Congress have disclosed 1 RLAY trade since 2023, 0 purchases and 1 sale in the past year; the latest was Daniel S. Goldman (D-NY), selling $1K–15K on Jul 12, 2023.
Who is the largest holder of RLAY?
Among 13F filers, Sb Investment Advisers (UK) Ltd reports the largest RLAY position, $522.1M (27,904,963 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Casdin Capital, LLC's: 15.0% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.